Mauro Chiarito, Jorge Sanz-Sanchez, Raffaele Piccolo, Francesco Condello, Gaetano Liccardo, Matteo Maurina, Marisa Avvedimento, Damiano Regazzoli, Paolo Pagnotta, Hector M Garcia-Garcia, Roxana Mehran, Massimo Federici, Gianluigi Condorelli, Jose Luis Diez Gil, Bernhard Reimers, Giuseppe Ferrante, Giulio Stefanini
BACKGROUND: Despite paucity of data, it is common practice to discontinue metformin before invasive coronary angiography due to an alleged risk of Metformin-Associated Lactic Acidosis (M-ALA). We aimed at assessing the safety of metformin continuation in diabetic patients undergoing coronary angiography in terms of significant increase in lactate levels. METHODS: In this open-label, prospective, multicentre, single-arm trial, all diabetic patients undergoing coronary angiography with or without percutaneous coronary intervention at 3 European centers were screened for enrolment...
February 6, 2023: Cardiovascular Diabetology